AboutCOVID-19Careers in pharmacologyNewsEventsEducation & engagementPartner with UsPublishingMembership & awardsMy BPS & resources

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

Article date: September 1982

By: JA Millar, FH Derkx, K McLean, JL Reid, in Volume 14, Issue 3, pages 347-355

DOI: 10.1111/j.1365-2125.1982.tb01990.x

View this article

Publishing

Contact us

About this website

Become a member

BPS Assessment Ltd

BPS on LinkedIn BPS on Bluesky BPS on Facebook BPS on Instagram BPS on Reddit BPS on ThreadsBPS on YouTube

British Pharmacological Society is a registered UK charity - Charity No. 1030623. It is also a company limited by guarantee registered in England and Wales - Company Number 2877400.
Its registered office is The Schild Plot, 16 Angel Gate, City Road, London, EC1V 2PT, United Kingdom

© 2025 British Pharmacological Society. All rights reserved.